90 related articles for article (PubMed ID: 4614903)
1. 100% oxygen inhalation and 5-fluorouracil (NSC-19893) therapy for large bowel carcinoma.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Chemother Rep; 1974; 58(6):951-2. PubMed ID: 4614903
[No Abstract] [Full Text] [Related]
2. A comparison of 5-fluorouracil administered by slow infusion and rapid injection.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Dec; 32(12):2717-9. PubMed ID: 4566290
[No Abstract] [Full Text] [Related]
3. 5-day iv infusion with 5-fluorouracil (5-FU; NSC-19893) for gastroenteric carcinoma after failure on weekly 5-FU therapy.
Hum GJ; Bateman JR
Cancer Chemother Rep; 1975; 59(6):1171-9. PubMed ID: 769960
[No Abstract] [Full Text] [Related]
4. [The use of 5-fluorouracil in the therapy of some epithelial tumors].
Traldi A; Morini A
Minerva Med; 1966 Mar; 57(25):1146-9. PubMed ID: 5932019
[No Abstract] [Full Text] [Related]
5. 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.
Stolinsky DC; Pugh RP; Bateman JR
Cancer Chemother Rep; 1975; 59(5):1031-3. PubMed ID: 1106846
[No Abstract] [Full Text] [Related]
6. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
Zaanan A; Gauthier M; Malka D; Locher C; Gornet JM; Thirot-Bidault A; Tougeron D; Taïeb J; Bonnetain F; Aparicio T;
Cancer; 2011 Apr; 117(7):1422-8. PubMed ID: 21425142
[TBL] [Abstract][Full Text] [Related]
7. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).
Tucker WG; Talley RW; Lane M; Bonnet JD
Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101
[No Abstract] [Full Text] [Related]
8. 5-Fluorouracil as adjuvant chemotherapy for large bowel cancer. Is it appropriate for routine community use?
Carter SK
Cancer Chemother Pharmacol; 1979; 2(2):81-4. PubMed ID: 394874
[No Abstract] [Full Text] [Related]
9. [Experience with the treatment of patients with malignant tumors with 5-fluorouracil].
Milonov BV; Kosarev VA; Nikiforov AM
Vopr Onkol; 1967; 13(12):55-61. PubMed ID: 5597532
[No Abstract] [Full Text] [Related]
10. Phase II study of bleomycin (NSC-125066) therapy for large bowel cancer.
Moertel CG; Arena PJ; Schutt AJ; Reitemeir RJ; Hahn RG
Cancer Chemother Rep; 1972 Apr; 56(2):207-10. PubMed ID: 4114486
[No Abstract] [Full Text] [Related]
11. Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma.
Trikudanathan G; Dasanu CA
Expert Opin Pharmacother; 2010 Jul; 11(10):1695-704. PubMed ID: 20446863
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of large bowel cancer.
Davis HL
Cancer; 1982 Dec; 50(11 Suppl):2638-46. PubMed ID: 6215979
[No Abstract] [Full Text] [Related]
13. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
Abdallah AM; Soukop M; Bell G; Calman KC
Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
[No Abstract] [Full Text] [Related]
14. Weekly large fraction radiotherapy and 5 fluorouracil as a palliative treatment for large bowel carcinoma: a pilot study.
Habeshaw T; Adam JS; Kirk J
Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1127-30. PubMed ID: 6181043
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adriamycin (NSC-123127) and 5-fluorouracil (NSC-19893) in advanced prostatic cancer.
DeWys WD
Cancer Chemother Rep; 1975; 59(1):215-7. PubMed ID: 1093668
[No Abstract] [Full Text] [Related]
16. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
[No Abstract] [Full Text] [Related]
17. Clinical management of advanced gastrointestinal cancer.
Moertel C
Semin Drug Treat; 1973; 3(1):55-68. PubMed ID: 4351814
[No Abstract] [Full Text] [Related]
18. [A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)].
Queisser W; Schaefer J; Arnold H; Drings P; Geldmacher J; Hartwich G; Kredel L; Mayer M; Neidhardt B; von Oldershausen HF; Rösch W; Wahrendorf J
Dtsch Med Wochenschr; 1979 Aug; 104(35):1231. PubMed ID: 383437
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
Brugarolas A; Rivas A; Lacave AJ; Gonzalez-Palacois F; Froufe A
Cancer Chemother Rep; 1975; 59(5):1025-6. PubMed ID: 1106844
[No Abstract] [Full Text] [Related]
20. [Cyclophosphamide, methotrexate and 5-fluorouracil (CMF), versus 5-fluorouracil, in carcinoma of the large intestine in an advanced stage].
Scanni A; Tomirotti M; Biraghi M; Annibali E; Del Bianco S
Minerva Med; 1980 Mar; 71(10):799-801. PubMed ID: 7360368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
